Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LQ.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
MD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FY.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDKSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.54SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDK.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.28.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDQ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.14.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DY.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.14.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.51.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDD.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.7 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.14.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DZ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.14.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DY.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.14.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.65SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DT.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.63SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.53SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DF.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used